US Edition
News from Simcoe.com
We’ve assigned a rating of High factuality to Simcoe.com. You can read more about how we’ve determined Simcoe.com’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Average Bias Rating:
Lean Left
Lean Left
byMedia Bias/Fact CheckDo you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Simcoe.com News
TechnologyAcquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a new standard of care in combination in first line unfit acute myeloid leukemia, an aggressive blood cancer affecting older adults Ipsen to acquire all issued and outstanding shares of ImCheck Therapeutics, for which ImCheck Therapeutics' shareholde…See the Story
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline - Ipsen (OTC:IPSEY)
60% Left coverage: 10 sources
Work · United KingdomAcronis released its 2025 WIT Report "FOMO at Work: The Opportunity Gap Between Men and Women in Tech” uncovering career barriers in the tech sector....See the Story
FOMO at Work: 82% of Women in Tech Say More Female Leaders Would Improve Workplace Culture, Acronis Report Reveals
50% Left coverage: 4 sources
